輸入代號或公司名稱後按 Enter
HROW

HARROW, INC.

-0.92 (-2.68%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 生技醫療 · Pharmaceutical Preparations
33.29USD236K成交股數1.2B市值本益比(近四季)4.5股價營收比+10.8%營收年增(近四季)2026-11-09下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收70.7M+11%44.2M-8%89.1M+81%71.6M+46%63.7M+84%47.8M+32%49.3M+44%48.9M+46%34.6M36.4M34.3M33.5M
營業成本20.3M17.2M18.5M17.7M16.2M15.5M12.0M12.5M10.6M11.3M10.1M10.0M
毛利50.4M+6%27.0M-16%70.6M+90%53.9M+48%47.5M+98%32.3M+29%37.2M+54%36.4M+55%24.0M25.1M24.2M23.5M
毛利率71.3%61.2%79.3%75.3%74.5%67.5%75.6%74.4%69.5%68.9%70.6%70.1%
研發費用8.1M5.9M11.7M3.3M2.9M3.0M2.3M3.1M2.1M3.3M1.4M1.2M
銷售管理費用53.3M43.2M43.3M35.9M33.2M40.5M33.6M31.8M28.8M26.2M21.0M20.0M
營業利益−11.0M-196%−22.1M+97%15.6M+1080%14.7M+864%11.4M-265%−11.2M+130%1.3M-24%1.5M-35%−6.9M−4.9M1.7M2.4M
營業利益率-15.6%-50.0%17.5%20.6%17.9%-23.5%2.7%3.1%-20.0%-13.4%5.1%7.0%
稅後淨利−17.3M-446%−27.6M+55%6.6M-257%1.0M-116%5.0M-137%−17.8M+94%−4.2M-4%−6.5M+53%−13.6M−9.1M−4.4M−4.2M
淨利率-24.4%-62.4%7.4%1.4%7.8%-37.2%-8.6%-13.2%-39.2%-25.2%-12.8%-12.6%
稀釋 EPS-0.46-454%-0.74+48%0.20-267%0.03-117%0.13-134%-0.50+92%-0.12-8%-0.18+29%-0.38-0.26-0.13-0.14
稀釋股數37.4M37.2M36.8M38.9M38.9M35.8M35.7M35.6M35.5M32.6M34.3M30.5M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金83.9M94.6M72.9M74.3M53.0M66.7M72.6M71.0M68.5M74.1M65.6M22.8M
應收帳款119M101M111M77.6M78.8M77.1M53.7M52.0M29.0M36.3M18.5M18.3M
存貨16.9M16.5M13.5M12.8M11.6M10.7M10.2M9.4M10.8M10.9M8.9M8.6M
總資產417M420M399M363M345M364M352M307M296M312M286M224M
有息負債300M250M347M251M257M231M236M243M247M252M240M
總負債402M391M347M316M296M308M294M248M235M242M211M202M
股東權益15.2M28.7M52.4M47.0M49.7M56.5M58.0M58.5M60.6M70.8M75.8M22.4M
負債比96.4%93.2%87.0%87.1%85.7%84.6%83.6%81.0%79.6%77.4%73.6%90.2%
淨現金(現金 − 有息負債)−205M−177M−273M−198M−190M−158M−165M−175M−173M−186M−217M

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流−9.0M-146%19.7M−4.6M
資本支出194K170K92K
自由現金流−9.2M-147%19.5M−4.7M
折舊攤銷455K330K326K347K312K351K301K296K
買回庫藏股
現金股利
自由現金流率-20.8%40.8%-13.6%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 272M
Branded196M71.9%+68.6%
Imprimis Rx76.5M28.1%-8.3%
產品/服務2025 年度 · 468M
Product Sales Net272M58.1%+36.9%
VEVYE88.7M18.9%+216.1%
IHEEZO81.3M17.4%+65.0%
Other Products25.3M5.4%-33.1%
Other Revenue394K0.1%-56.9%
Other Revenues394K0.1%-60.4%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025272M+36.4%−5.1M-1.9%-0.1443.0M
FY2024200M+53.3%−17.5M-8.8%-0.49−23.8M
FY2023130M+47.0%−24.4M-18.7%-0.752.4M
FY202288.6M+22.2%−14.1M-15.9%-0.51−892K
FY202172.5M+48.3%−18.0M-24.8%-0.693.3M
FY202048.9M-4.5%−3.4M-6.9%-0.13−2.0M
FY201951.2M+23.7%168K0.3%0.01−518K
FY201841.4M14.6M35.3%0.61−1.1M